Wide-ranging health care regulatory counsel

Shaylynn Veeder advises health care providers and suppliers on a variety of regulatory issues arising under Medicare, Medicaid and fraud and abuse laws, including Anti-Kickback, Physician Self-Referral and false claims laws. She provides guidance on health information privacy matters, licensing issues and health care regulatory due diligence in relation to transaction matters. Shaylynn also regularly advises clients on FDA regulatory issues and corporate compliance concerns. Her experience also includes:

• Counseling clients regarding the SUPPORT Act's all-payor federal anti-kickback law, the Eliminating Kickbacks in Recovery Act of 2018 (EKRA).
• Advising clients regarding FDA Form 483 Feasibility Study Program and radiation emitting products.
• Reviewing and advising on change of ownership requirements for provider and supplier contracts.
• Managing client hospice and home health contracts with the U.S. Department of Veterans Affairs.

Admitted in Maryland and the District of Columbia.

Bar Admissions

• District of Columbia
• Maryland

Education

• Georgetown University Law Center (J.D., 2017)
  • Society for Health Law and Bioethics, vice president
  • Phi Alpha Delta, representative
  • Women's Legal Alliance, mentor
  • Medical-Legal Partnership Practicum

• Arizona State University, Barrett, The Honors College (B.S., summa cum laude, 2014)
  • Political Science/Justice Studies
  • Honors certificate in Philosophy, Politics and Law
  • Thesis: The Bioethics of Cell-free Fetal DNA Testing

• "How to Prepare for the MPJE"
• "Pharmacy Law Update"
• California Follows the Lead of Other States in Heightening the Scrutiny of Health Care Transactions
• FDA May Require Opioids to be Dispensed with Mail-Back Envelopes and Related Patient Education
• Ohio Board of Pharmacy Formalizes a Pathway for Approval of Innovative Pharmacy Arrangements
• The Clock is Ticking: Comments to Proposed Federal Rules For Wholesalers and 3PLs are Due June 6th and Here’s What We Think